Moulay A. Alaoui-Jamali - Publications

Affiliations: 
McGill University, Montreal, QC, Canada 
Area:
Molecular Biology, Oncology, Microbiology Biology

92 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Bakkar A, Alshalalfa M, Petersen LF, Abou-Ouf H, Al-Mami A, Hegazy SA, Feng F, Alhajj R, Bijian K, Alaoui-Jamali MA, Bismar TA. microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patients. Molecular Biology Reports. PMID 26907180 DOI: 10.1007/s11033-016-3948-4  0.4
2015 da Silva SD, Marchi FA, Xu B, Bijian K, Alobaid F, Mlynarek A, Rogatto SR, Hier M, Kowalski LP, Alaoui-Jamali MA. Predominant Rab-GTPase amplicons contributing to oral squamous cell carcinoma progression to metastasis. Oncotarget. PMID 26110570  0.4
2015 Alaoui-Jamali MA, Morand GB, da Silva SD. ErbB polymorphisms: insights and implications for response to targeted cancer therapeutics. Frontiers in Genetics. 6: 17. PMID 25699077 DOI: 10.3389/fgene.2015.00017  0.4
2015 da Silva SD, Morand GB, Alobaid FA, Hier MP, Mlynarek AM, Alaoui-Jamali MA, Kowalski LP. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma. Clinical & Experimental Metastasis. 32: 55-63. PMID 25433796 DOI: 10.1007/s10585-014-9690-1  0.4
2015 Alaoui-Jamali MA, Cao YH, Bijian K, Alkailani MI. Tumor-derived exosomes in metastasis signaling and implications Intercellular Communication in Cancer. 189-200. DOI: 10.1007/978-94-017-7380-5_7  0.4
2014 Morand GB, da Silva SD, Hier MP, Alaoui-Jamali MA. Insights into genetic and epigenetic determinants with impact on vitamin d signaling and cancer association studies: the case of thyroid cancer. Frontiers in Oncology. 4: 309. PMID 25414832 DOI: 10.3389/fonc.2014.00309  0.4
2014 Xu B, Teng LH, Silva SD, Bijian K, Al Bashir S, Jie S, Dolph M, Alaoui-Jamali MA, Bismar TA. The significance of dynamin 2 expression for prostate cancer progression, prognostication, and therapeutic targeting. Cancer Medicine. 3: 14-24. PMID 24402972 DOI: 10.1002/cam4.168  0.4
2014 Silva SD, Alaoui-Jamali MA, Hier M, Soares FA, Graner E, Kowalski LP. Cooverexpression of ERBB1 and ERBB4 receptors predicts poor clinical outcome in pN+ oral squamous cell carcinoma with extranodal spread. Clinical & Experimental Metastasis. 31: 307-16. PMID 24338375 DOI: 10.1007/s10585-013-9629-y  0.4
2014 da Silva SD, Alaoui-Jamali MA, Soares FA, Carraro DM, Brentani HP, Hier M, Rogatto SR, Kowalski LP. TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target. Cancer. 120: 352-62. PMID 24150986 DOI: 10.1002/cncr.28404  0.4
2013 Bijian K, Lougheed C, Su J, Xu B, Yu H, Wu JH, Riccio K, Alaoui-Jamali MA. Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine British Journal of Cancer. 109: 2810-2818. PMID 24169345 DOI: 10.1038/bjc.2013.675  0.4
2013 Jin H, Zhang P, Bijian K, Ren S, Wan S, Alaoui-Jamali MA, Jiang T. Total synthesis and biological activity of marine alkaloid Eudistomins Y1-Y7 and their analogues. Marine Drugs. 11: 1427-39. PMID 23629726 DOI: 10.3390/md11051427  0.4
2013 Garcia AG, Nedev H, Bijian K, Su J, Alaoui-Jamali MA, Saragovi HU. Reduced in vivo lung metastasis of a breast cancer cell line after treatment with Herceptin mAb conjugated to chemotherapeutic drugs. Oncogene. 32: 2527-33. PMID 22797066 DOI: 10.1038/onc.2012.283  0.4
2012 da Silva SD, Hier M, Mlynarek A, Kowalski LP, Alaoui-Jamali MA. Recurrent oral cancer: current and emerging therapeutic approaches. Frontiers in Pharmacology. 3: 149. PMID 23060791 DOI: 10.3389/fphar.2012.00149  0.4
2012 Bijian K, Zhang Z, Xu B, Jie S, Chen B, Wan S, Wu J, Jiang T, Alaoui-Jamali MA. Synthesis and biological activity of novel organoselenium derivatives targeting multiple kinases and capable of inhibiting cancer progression to metastases. European Journal of Medicinal Chemistry. 48: 143-52. PMID 22204902 DOI: 10.1016/j.ejmech.2011.12.006  0.4
2011 Alaoui-Jamali MA, Bijian K, Batist G. Emerging drug discovery approaches for selective targeting of "precursor" metastatic breast cancer cells: Highlights and perspectives American Journal of Translational Research. 3: 434-444.  0.4
2010 Xu Y, Bismar TA, Su J, Xu B, Kristiansen G, Varga Z, Teng L, Ingber DE, Mammoto A, Kumar R, Alaoui-Jamali MA. Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion. The Journal of Experimental Medicine. 207: 2421-37. PMID 20937704 DOI: 10.1084/jem.20100433  0.4
2009 Xu Y, Benlimame N, Su J, He Q, Alaoui-Jamali MA. Regulation of focal adhesion turnover by ErbB signalling in invasive breast cancer cells British Journal of Cancer. 100: 633-643. PMID 19190626 DOI: 10.1038/sj.bjc.6604901  0.4
2009 Poondra RR, Kumar NN, Bijian K, Prakesch M, Campagna-Slater V, Reayi A, Reddy PT, Choudhry A, Barnes ML, Leek DM, Daroszewska M, Lougheed C, Xu B, Schapira M, Alaoui-Jamali MA, et al. Discovery of indoline-based, natural-product-like compounds as probes of focal adhesion kinase signaling pathways. Journal of Combinatorial Chemistry. 11: 303-9. PMID 19146410 DOI: 10.1021/cc8001525  0.4
2008 Behmoaram E, Bijian K, Bismar TA, Alaoui-Jamali MA. Early stage cancer cell invasion: signaling, biomarkers and therapeutic targeting. Frontiers in Bioscience : a Journal and Virtual Library. 13: 6314-25. PMID 18508662  0.4
2007 Hamilton D, Loignon M, Alaoui-Jamali MA, Batist G. Novel use of the fluorescent dye 5-(and-6)-chloromethyl SNARF-1 acetate for the measurement of intracellular glutathione in leukemic cells and primary lymphocytes. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 71: 709-15. PMID 17623874 DOI: 10.1002/cyto.a.20433  0.4
2007 Li B, Lyle MP, Chen G, Li J, Hu K, Tang L, Alaoui-Jamali MA, Webster J. Substituted 6-amino-4H-[1,2]dithiolo[4,3-b]pyrrol-5-ones: synthesis, structure-activity relationships, and cytotoxic activity on selected human cancer cell lines. Bioorganic & Medicinal Chemistry. 15: 4601-8. PMID 17467996 DOI: 10.1016/j.bmc.2007.04.017  0.4
2007 Darwish H, Cho JM, Loignon M, Alaoui-Jamali MA. Overexpression of SERTAD3, a putative oncogene located within the 19q13 amplicon, induces E2F activity and promotes tumor growth Oncogene. 26: 4319-4328. PMID 17260023 DOI: 10.1038/sj.onc.1210195  0.4
2006 Alaoui-Jamali MA. Protein tyrosine kinase signaling diversity and susceptibility to targeted kinase inhibitors Biomedicine and Pharmacotherapy. 60: 629-632. PMID 16949787 DOI: 10.1016/j.biopha.2006.08.003  0.4
2006 Kalra J, Shao Q, Qin H, Thomas T, Alaoui-Jamali MA, Laird DW. Cx26 inhibits breast MDA-MB-435 cell tumorigenic properties by a gap junctional intercellular communication-independent mechanism. Carcinogenesis. 27: 2528-37. PMID 16777986 DOI: 10.1093/carcin/bgl110  0.4
2006 Alaoui-Jamali MA, Xu YJ. Proteomic technology for biomarker profiling in cancer: an update. Journal of Zhejiang University. Science. B. 7: 411-20. PMID 16625706 DOI: 10.1631/jzus.2006.B0411  0.4
2006 Luh SP, Alaoui-Jamali MA. New targets, new agents, and the evolving phenomena of drug resistance in cancer Current Cancer Therapy Reviews. 2: 23-30. DOI: 10.2174/157339406775471821  0.4
2005 Benlimame N, He Q, Jie S, Xiao D, Xu YJ, Loignon M, Schlaepfer DD, Alaoui-Jamali MA. FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion. The Journal of Cell Biology. 171: 505-16. PMID 16275754 DOI: 10.1083/jcb.200504124  0.4
2005 Brahimi F, Rachid Z, McNamee JP, Alaoui-Jamali MA, Tari AM, Jean-Claude BJ. Mechanism of action of a novel "combi-triazene" engineered to possess a polar functional group on the alkylating moiety: evidence for enhancement of potency. Biochemical Pharmacology. 70: 511-9. PMID 15982640 DOI: 10.1016/j.bcp.2005.04.037  0.4
2004 Matheson SL, McNamee JP, Wang T, Alaoui-Jamali MA, Tari AM, Jean-Claude BJ. The combi-targeting concept: dissection of the binary mechanism of action of the combi-triazene SMA41 in vitro and antitumor activity in vivo. The Journal of Pharmacology and Experimental Therapeutics. 311: 1163-70. PMID 15358812 DOI: 10.1124/jpet.104.071977  0.4
2004 Chow TY, Alaoui-Jamali MA, Yeh C, Yuen L, Griller D. The DNA double-stranded break repair protein endo-exonuclease as a therapeutic target for cancer. Molecular Cancer Therapeutics. 3: 911-9. PMID 15299074  0.4
2004 Al Moustafa AE, Foulkes WD, Wong A, Jallal H, Batist G, Yu Q, Herlyn M, Sicinski P, Alaoui-Jamali MA. Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells. Oncogene. 23: 5252-6. PMID 15229656 DOI: 10.1038/sj.onc.1207679  0.4
2004 Kandouz M, Bier A, Carystinos GD, Alaoui-Jamali MA, Batist G. Connexin43 pseudogene is expressed in tumor cells and inhibits growth. Oncogene. 23: 4763-70. PMID 15122329 DOI: 10.1038/sj.onc.1207506  0.4
2004 Al Moustafa AE, Foulkes WD, Benlimame N, Wong A, Yen L, Bergeron J, Batist G, Alpert L, Alaoui-Jamali MA. E6/E7 proteins of HPV type 16 and ErbB-2 cooperate to induce neoplastic transformation of primary normal oral epithelial cells. Oncogene. 23: 350-8. PMID 14724563 DOI: 10.1038/sj.onc.1207148  0.4
2004 Aloyz R, Grzywacz K, Xu ZY, Loignon M, Alaoui-Jamali MA, Panasci L. Imatinib sensitizes CLL lymphocytes to chlorambucil Leukemia. 18: 409-414. PMID 14712290 DOI: 10.1038/sj.leu.2403247  0.4
2003 Qin H, Shao Q, Thomas T, Kalra J, Alaoui-Jamali MA, Laird DW. Connexin26 regulates the expression of angiogenesis-related genes in human breast tumor cells by both GJIC-dependent and -independent mechanisms. Cell Communication & Adhesion. 10: 387-93. PMID 14681046  0.4
2003 Scrivens PJ, Alaoui-Jamali MA, Giannini G, Wang T, Loignon M, Batist G, Sandor VA. Cdc25A-inhibitory properties and antineoplastic activity of bisperoxovanadium analogues. Molecular Cancer Therapeutics. 2: 1053-9. PMID 14578470  0.4
2003 Qin H, Shao Q, Igdoura SA, Alaoui-Jamali MA, Laird DW. Lysosomal and proteasomal degradation play distinct roles in the life cycle of Cx43 in gap junctional intercellular communication-deficient and -competent breast tumor cells. The Journal of Biological Chemistry. 278: 30005-14. PMID 12767974 DOI: 10.1074/jbc.M300614200  0.4
2003 Alaoui-Jamali MA, Qiang H. The interface between ErbB and non-ErbB receptors in tumor invasion: clinical implications and opportunities for target discovery. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 6: 95-107. PMID 12729807 DOI: 10.1016/S1368-7646(03)00024-4  0.4
2003 Carystinos GD, Kandouz M, Alaoui-Jamali MA, Batist G. Unexpected induction of the human connexin 43 promoter by the ras signaling pathway is mediated by a novel putative promoter sequence. Molecular Pharmacology. 63: 821-31. PMID 12644583 DOI: 10.1124/mol.63.4.821  0.4
2002 Yen L, Benlimame N, Nie ZR, Xiao D, Wang T, Al Moustafa AE, Esumi H, Milanini J, Hynes NE, Pages G, Alaoui-Jamali MA. Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers. Molecular Biology of the Cell. 13: 4029-44. PMID 12429844 DOI: 10.1091/mbc.E02-02-0084  0.4
2002 Aloyz R, Xu ZY, Bello V, Bergeron J, Han FY, Yan Y, Malapetsa A, Alaoui-Jamali MA, Duncan AM, Panasci L. Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD. Cancer Research. 62: 5457-62. PMID 12359753  0.4
2002 Al Moustafa AE, Yen L, Benlimame N, Alaoui-Jamali MA. Regulation of E-cadherin/catenin complex patterns by epidermal growth factor receptor modulation in human lung cancer cells. Lung Cancer (Amsterdam, Netherlands). 37: 49-56. PMID 12057867 DOI: 10.1016/S0169-5002(02)00025-9  0.4
2002 Qin H, Shao Q, Curtis H, Galipeau J, Belliveau DJ, Wang T, Alaoui-Jamali MA, Laird DW. Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication. The Journal of Biological Chemistry. 277: 29132-8. PMID 12042301 DOI: 10.1074/jbc.M200797200  0.4
2002 Al Moustafa AE, Alaoui-Jamali MA, Batist G, Hernandez-Perez M, Serruya C, Alpert L, Black MJ, Sladek R, Foulkes WD. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene. 21: 2634-40. PMID 11965536 DOI: 10.1038/sj.onc.1205351  0.4
2002 Dupont E, Falardeau P, Mousa SA, Dimitriadou V, Pepin MC, Wang T, Alaoui-Jamali MA. Antiangiogenic and antimetastatic properties of Neovastat (AE-941), an orally active extract derived from cartilage tissue. Clinical & Experimental Metastasis. 19: 145-53. PMID 11964078 DOI: 10.1023/A:1014546909573  0.4
2001 Huynh H, Alpert L, Alaoui-Jamali MA, Ng CY, Chan TWM. Co-administration of finasteride and the pure anti-oestrogen ICI 182,780 act synergistically in modulating the IGF system in rat prostate Journal of Endocrinology. 171: 109-118. PMID 11572795 DOI: 10.1677/joe.0.1710109  0.4
2001 Trudeau C, Yuan S, Galipeau J, Benlimame N, Alaoui-Jamali MA, Batist G. A novel parasite-derived suicide gene for cancer gene therapy with specificity for lung cancer cells Human Gene Therapy. 12: 1673-1680. PMID 11535170 DOI: 10.1089/10430340152528165  0.4
2001 Marcantonio D, Chalifour LE, Alaoui-Jamali And H T Huynh MA, Alaoui-Jamali MA, Alaoui-Jamali MA, Huynh HT, Huynh HT. Steroid-sensitive gene-1 is an androgen-regulated gene expressed in prostatic smooth muscle cells in vivo. Journal of Molecular Endocrinology. 26: 175-84. PMID 11357054 DOI: 10.1677/jme.0.0260175  0.4
2001 Marcantonio D, Chalifour LE, Alaoui-Jamali MA, Alpert L, Huynh HT. Cloning and characterization of a novel gene that is regulated by estrogen and is associated with mammary gland carcinogenesis. Endocrinology. 142: 2409-18. PMID 11356689 DOI: 10.1210/endo.142.6.8154  0.4
2001 Prudencio J, Akutsu N, Benlimame N, Wang T, Bastien Y, Lin R, Black MJ, Alaoui-Jamali MA, White JH. Action of low calcemic 1α,25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinoma Journal of the National Cancer Institute. 93: 745-753. PMID 11353784  0.4
2001 Zhang J, Sauriol F, Mamer O, You XL, Alaoui-Jamali MA, Batist G, Zamir LO. New taxane analogues from the needles of Taxus canadensis Journal of Natural Products. 64: 450-455. PMID 11325226 DOI: 10.1021/np0004449  0.4
2001 Jaitovich-Groisman I, Benlimame N, Slagle BL, Perez MH, Alpert L, Song DJ, Fotouhi-Ardakani N, Galipeau J, Alaoui-Jamali MA. Transcriptional Regulation of the TFIIH Transcription Repair Components XPB and XPD by the Hepatitis B Virus x Protein in Liver Cells and Transgenic Liver Tissue Journal of Biological Chemistry. 276: 14124-14132. PMID 11278765  0.4
2001 Carystinos GD, Alaoui-Jamali MA, Phipps J, Yen L, Batist G. Upregulation of gap junctional intercellular communication and connexin 43 expression by cyclic-AMP and all-trans-retinoic acid is associated with glutathione depletion and chemosensitivity in neuroblastoma cells Cancer Chemotherapy and Pharmacology. 47: 126-132. PMID 11269738 DOI: 10.1007/s002800000231  0.4
2001 Huynh HT, Alpert L, Laird DW, Batist G, Chalifour L, Alaoui-Jamali MA. Regulation of the gap junction connexin 43 gene by androgens in the prostate. Journal of Molecular Endocrinology. 26: 1-10. PMID 11174849 DOI: 10.1677/jme.0.0260001  0.4
2000 Bergeron J, Benlimame N, Zeng-Rong N, Xiao D, Scrivens PJ, Koromilas AE, Alaoui-Jamali MA. Identification of the interferon-inducible double-stranded RNA-dependent protein kinase as a regulator of cellular response to bulky adducts Cancer Research. 60: 6800-6804. PMID 11156368  0.4
2000 Cho JM, Song DJ, Bergeron J, Benlimame N, Wold MS, Alaoui-Jamali MA. RBT1, a novel transcriptional co-activator, binds the second subunit of replication protein A. Nucleic Acids Research. 28: 3478-85. PMID 10982866  0.4
2000 Jaitovitch-Groisman I, Fotouhi-Ardakani N, Schecter RL, Woo A, Alaoui-Jamali MA, Batist G. Modulation of glutathione S-transferase alpha by hepatitis B virus and the chemopreventive drug oltipraz Journal of Biological Chemistry. 275: 33395-33403. PMID 10934196 DOI: 10.1074/jbc.M003754200  0.4
2000 Yen L, You XL, Al Moustafa AE, Batist G, Hynes NE, Mader S, Meloche S, Alaoui-Jamali MA. Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis Oncogene. 19: 3460-3469. PMID 10918604  0.4
2000 Sohn S, Jaitovitch-Groisman I, Benlimame N, Galipeau J, Batist G, Alaoui-Jamali MA. Retroviral expression of the hepatitis B virus x gene promotes liver cell susceptibility to carcinogen-induced site specific mutagenesis Mutation Research - Dna Repair. 460: 17-28. PMID 10856831 DOI: 10.1016/S0921-8777(00)00010-0  0.4
1999 Laird DW, Fistouris P, Batist G, Alpert L, Huynh HT, Carystinos GD, Alaoui-Jamali MA. Deficiency of connexin43 gap junctions is an independent marker for breast tumors. Cancer Research. 59: 4104-10. PMID 10463615  0.4
1999 Horton JK, Roy G, Piper JT, Van Houten B, Awasthi YC, Mitra S, Alaoui-Jamali MA, Boldogh I, Singhal SS. Characterization of a chlorambucil-resistant human ovarian carcinoma cell line overexpressing glutathione S-transferase μ Biochemical Pharmacology. 58: 693-702. PMID 10413308 DOI: 10.1016/S0006-2952(99)00142-2  0.4
1999 Groisman IJ, Koshy R, Henkler F, Groopman JD, Alaoui-Jamali MA. Downregulation of DNA excision repair by the hepatitis B virus-x protein occurs in p53-proficient and p53-deficient cells. Carcinogenesis. 20: 479-83. PMID 10190565  0.4
1999 Moustafa AEA, Yansouni C, Alaoui-Jamali MA, O'Connor-McCourt M. Up-regulation of E-cadherin by an anti-epidermal growth factor receptor monoclonal antibody in lung cancer cell lines Clinical Cancer Research. 5: 681-686. PMID 10100722  0.4
1999 Carystinos GD, Katabi MM, Laird DW, Galipeau J, Chan H, Alaoui-Jamali MA, Batist G. Cyclic-AMP induction of gap junctional intercellular communication increases bystander effect in suicide gene therapy Clinical Cancer Research. 5: 61-68. PMID 9918203  0.4
1998 Arya P, Alibhai N, Qin H, Burton GW, Batist G, You SXL, Alaoui-Jamali MA. Design and synthesis of analogs of vitamin E: Antiproliferative activity against human breast adenocarcinoma cells Bioorganic and Medicinal Chemistry Letters. 8: 2433-2438. PMID 9873556 DOI: 10.1016/S0960-894X(98)00438-7  0.4
1998 You XL, Yen L, Zeng-Rong N, Al Moustafa AE, Alaoui-Jamali MA. Dual effect of erbB-2 depletion on the regulation of DNA repair and cell cycle mechanisms in non-small cell lung cancer cells Oncogene. 17: 3177-3186. PMID 9872333  0.4
1998 Paterson J, Uriel C, Egron MJ, Herscovici J, Antonakis K, Alaoui-Jamali MA. Antiproliferative and apoptotic activities of ketonucleosides and keto- C-glycosides against non-small-cell lung cancer cells with intrinsic drug resistance Antimicrobial Agents and Chemotherapy. 42: 779-784. PMID 9559782  0.4
1997 Alaoui-Jamali MA, Paterson J, Al Moustafa AE, Yen L. The role of ErbB-2 tyrosine kinase receptor in cellular intrinsic chemoresistance: Mechanisms and implications Biochemistry and Cell Biology. 75: 315-325. PMID 9493954  0.4
1997 Yen L, Zeng-Rong N, You XL, Richard S, Langton-Webster BC, Alaoui-Jamali MA. Regulation of cellular response to cisplatin-induced DNA damage and DNA repair in cells overexpressing p185(erbB-2) is dependent on the ras signaling pathway Oncogene. 14: 1827-1835. PMID 9150389  0.4
1996 Kirby GM, Batist G, Fotouhi-Ardakani N, Nakazawa H, Yamasaki H, Kew M, Cameron RG, Alaoui-Jamali MA. Allele-specific PCR analysis of p53 codon 249 AGT transversion in liver tissues from patients with viral hepatitis International Journal of Cancer. 68: 21-25. PMID 8895534 DOI: 10.1002/(SICI)1097-0215(19960927)68:1<21::AID-IJC4>3.0.CO;2-Z  0.4
1996 Kirby GM, Batist G, Alpert L, Lamoureux E, Cameron RG, Alaoui-Jamali MA. Overexpression of cytochrome P-450 isoforms involved in aflatoxin B1 bioactivation in human liver with cirrhosis and hepatitis Toxicologic Pathology. 24: 458-467. PMID 8864187  0.4
1995 Zeng-Rong N, Paterson J, Alpert L, Alaoui-Jamali MA, Tsao MS, Viallet J. Elevated DNA Repair Capacity Is Associated with Intrinsic Resistance of Lung Cancer to Chemotherapy Cancer Research. 55: 4760-4764. PMID 7585500  0.4
1995 Yen L, Woo A, Christopoulopoulos G, Batist G, Panasci L, Roy R, Mitra S, Alaoui-Jamali MA. Enhanced host cell reactivation capacity and expression of DNA repair genes in human breast cancer cells resistant to bi-functional alkylating agents Mutation Research-Dna Repair. 337: 179-189. PMID 7491121 DOI: 10.1016/0921-8777(95)00022-C  0.4
1994 C.-Gaudreault R, Alaoui-Jamali MA, Batist G, Béchard P, Lacroix J, Poyet P. Lack of cross-resistance to a new cytotoxic arylchloroethyl urea in various drug-resistant tumor cells Cancer Chemotherapy and Pharmacology. 33: 489-492. PMID 8137459 DOI: 10.1007/BF00686506  0.4
1993 Alaoui-Jamali MA, Schecter RL, Rustum YM, Centurioni MG, Lehnert S, Batist G. In vivo reversal of doxorubicin resistance by a new tiapamil analog Ro11- 2933 Journal of Pharmacology and Experimental Therapeutics. 264: 1299-1304. PMID 8450465  0.4
1993 Schecter RL, Alaoui-Jamali MA, Woo A, Fahl WE, Batist G. Expression of a rat glutathione-S-transferase complementary DNA in rat mammary carcinoma cells: impact upon alkylator-induced toxicity. Cancer Research. 53: 4900-6. PMID 8402679  0.4
1992 Alaoui-Jamali MA, Batist G, Lehnert S. Radiation-induced damage to DNA in drug- and radiation-resistant sublines of a human breast cancer cell line Radiation Research. 129: 37-42. PMID 1728055  0.4
1992 Alaoui-Jamali MA, Panasci L, Centurioni GM, Schecter R, Lehnert S, Batist G. Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activity Cancer Chemotherapy and Pharmacology. 30: 341-347. PMID 1505071 DOI: 10.1007/BF00689960  0.4
1992 Schecter RL, Alaoui-Jamali MA, Batist G. Glutathione S-transferase in chemotherapy resistance and in carcinogenesis Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 70: 349-353. PMID 1353967  0.4
1991 Alaoui-Jamali MA, Rossignol G, Castonguay A. Protective effects of vitamin A against the genotoxicity of NNK, a nicotine-derived N-nitrosamine Carcinogenesis. 12: 379-384. PMID 2009584 DOI: 10.1093/carcin/12.3.379  0.4
1991 Liu L, Alaoui-Jamali MA, el Alami N, Castonguay A. Characterization of activation and deactivation pathways of 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK) in rat hepatocytes Iarc Scientific Publications. 510-515. PMID 1855907  0.4
1991 Alaoui-Jamali MA, Bélanger PM, Rossignol G, Castonguay A. Metabolism, sister chromatid exchanges, and DNA single-strand breaks induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and their modulation by vitamin A in vitro Cancer Research. 51: 3946-3950. PMID 1855212  0.4
1990 Alaoui-Jamali MA, Massey TE, Douglas A, Rossignol G, Castonguay A. In vitro metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by lung cells isolated from Syrian golden hamster Cancer Letters. 52: 49-55. PMID 2354419 DOI: 10.1016/0304-3835(90)90076-A  0.4
1990 Liu L, Alaoui-Jamali MA, El Alami N, Castonguay A. Metabolism and DNA single strand breaks induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its analogues in primary culture of rat hepatocytes Cancer Research. 50: 1810-1816. PMID 2306734  0.4
1990 Alaoui-Jamali MA, Gagnon R, El Alami N, Castonguay A. Cytotoxicity, sister-chromatid exchanges and DNA single-strand breaks induced by 4-oxo-4-(3-pyridyl)butanal, a metabolite of a tobacco-specific N-nitrosamine Mutation Research/Genetic Toxicology. 240: 25-33. PMID 2294414 DOI: 10.1016/0165-1218(90)90005-M  0.4
1989 Rossignol G, Alaoui-Jamali MA, Castonguay A, Schuller HM. Metabolism and DNA damage induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in fetal tissues of the Syrian golden hamster Cancer Research. 49: 5671-5676. PMID 2790785  0.4
1989 Alaoui-Jamali MA, Rossignol G, Schuller HM, Castonguay A. Transplacental genotoxicity of a tobacco-specific N-nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, in Syrian golden hamster Mutation Research/Genetic Toxicology. 223: 65-72. PMID 2654630 DOI: 10.1016/0165-1218(89)90063-3  0.4
1988 Alaoui-Jamali MA, Castonguay A, Schuller HM. In vitro genotoxicity of 4(methylnitrosamine)-1-(3-pyridyl) 1-butanone activated by hamster maternal and fetal tissues Carcinogenesis. 9: 2319-2324. PMID 3191579 DOI: 10.1093/carcin/9.12.2319  0.4
1987 Alaoui-Jamali MA, Tapiero H, Antonakis K, Chouroulinkov I. Cytotoxic potential of ketonucleosides Anticancer Research. 7: 501-504. PMID 3477123  0.4
1987 Alaoui-Jamali MA, Egron MJ, Bessodes M, Antonakis K, Chouroulinkov I. Relationship between the structure and cytotoxic activity of new unsaturated ketonucleosides tested on eight cell lines European Journal of Medicinal Chemistry. 22: 305-310. DOI: 10.1016/0223-5234(87)90267-4  0.4
1986 Alaoui-jamali MA, Lasne CL, Antonakis K, Chouroulinkov I. Absence of genotoxic effects in cells exposed to four ketonucleoside derivatives Mutagenesis. 1: 411-417. PMID 3331679 DOI: 10.1093/mutage/1.6.411  0.4
1986 Alaoui-Jamali MA, Nguyen PL, Chouroulinkov I, Truhaut R. Preliminary study on the toxicity of new cytostatic drugs: Ketonucleosides Comptes Rendus De L'Academie Des Sciences - Serie Iii. 303: 161-165.  0.4
Show low-probability matches.